166 related articles for article (PubMed ID: 1722253)
1. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
Hanson GR; Singh N; Bush L; Gibb JW
J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
3. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
[TBL] [Abstract][Full Text] [Related]
4. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
7. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam SP
J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
[TBL] [Abstract][Full Text] [Related]
9. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Westwood SC; Hanson GR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
[TBL] [Abstract][Full Text] [Related]
10. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
[TBL] [Abstract][Full Text] [Related]
11. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
Letter AA; Merchant K; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
[TBL] [Abstract][Full Text] [Related]
12. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
[TBL] [Abstract][Full Text] [Related]
13. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
[TBL] [Abstract][Full Text] [Related]
15. Comparison of responses by neuropeptide systems in rat to the psychotropic drugs, methamphetamine, cocaine and PCP.
Hanson GR; Midgley LP; Bush LG; Johnson M; Gibb JW
NIDA Res Monogr; 1989; 95():348. PubMed ID: 2484267
[No Abstract] [Full Text] [Related]
16. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
17. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
[TBL] [Abstract][Full Text] [Related]
18. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
19. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
20. Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
Hanson GR; Merchant KM; Letter AA; Bush L; Gibb JW
Eur J Pharmacol; 1988 Oct; 155(1-2):11-8. PubMed ID: 2907484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
